International Business News - VRUS http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Pharmasset Inc. said Tuesday its hepatitis C treatment candidate met safety goals in part of an early-stage study. The drug candidate, called R7128, was administered to patients over a four-week period in 1,000-milligram doses. The study involved 31 patients. http://www.ibtimes.com/articles/20080805/pharmasset-drug-passes-early-stage-goal.htm Tue, 05 Aug 2008 08:55:50 EDT Clinical-stage pharmaceutical company Pharmasset Inc. said Tuesday it has sold 1.45 million shares of stock to institutional investors, raising about $25.9 million. http://www.ibtimes.com/articles/20080715/pharmasset-says-it-sold-25-9-million-in-stock.htm Tue, 15 Jul 2008 12:22:07 EDT Clinical-stage pharmaceutical company Pharmasset Inc. said Monday that it has selected PSI-7851, a preclinical drug for treatment of hepatitis C virus, as its lead candidate for treatment of the disease. http://www.ibtimes.com/articles/20080519/pharmasset-chooses-lead-hepatitis-c-drug-candidate.htm Mon, 19 May 2008 08:00:16 EDT Among the stock activity stories for Friday, May 16, from AP Financial News: NEW YORK (AP) _ Shares of Melco PBL Entertainment Inc. fell Friday as investors largely discounted the benefits of the company's agreement with A-Max Holdings, according to an analyst. http://www.ibtimes.com/articles/20080516/movers-roundup-melco-pharmasset.htm Fri, 16 May 2008 14:32:46 EDT Shares of clinical-stage pharmaceutical company Pharmasset Inc. rose Friday after analysts expressed optimism about the company's hepatitis Cdrug candidate in partnership with Roche AG. http://www.ibtimes.com/articles/20080516/pharmasset-shares-up-analysts-upbeat-on-hepatitis-candidate.htm Fri, 16 May 2008 17:15:56 EDT Pharmasset Inc., a clinical-stage pharmaceutical company, said Friday its hepatitis C drug candidate R7128 met safety goals in an early-stage study. The study results were presented at the 43rd annual meeting of the European Association for the Study of the Liver in Milan. http://www.ibtimes.com/articles/20080425/pharmasset-hepatitis-c-drug-meets-safety-goal-in-study.htm Fri, 25 Apr 2008 14:54:11 EDT Shares of Pharmasset Inc. rose Wednesday, as a UBS analyst upgraded the antiviral drugmaker, citing its low share price and strong hepatitis B and C pipeline. Analyst Annabel Samimy lifted her ratin... http://www.ibtimes.com/articles/20080402/pharmasset-rises-on-ubs-upgrade.htm Wed, 02 Apr 2008 19:57:15 EDT Among the stock activity stories for Wednesday, April 2, from AP Financial News: Top stories: NEW YORK (AP) Shares of Randgold Resources Ltd. soared more than 10 percent Wednesday after the London-... http://www.ibtimes.com/articles/20080402/movers-roundup-randgold-resources-pff.htm Wed, 02 Apr 2008 14:24:55 EDT Among the stock activity stories for Tuesday, Feb. 19, from AP Financial News: NEW YORK (AP) _ Shares of Bucyrus International Inc. rose Tuesday, after several analysts boosted their price targets for the mining equipment maker, citing its better-than-expected financial outlook. http://www.ibtimes.com/articles/20080219/movers-roundup-bucyrus-pharmasset.htm Tue, 19 Feb 2008 14:17:15 EST Shares of Pharmasset Inc. reached a new all-time high Monday after the company said 85 percent of patients dosed with 1500 milligrams of its experimental drug R7128, in combination with Pegasys and Copegus, achieved undetectable levels of Hepatitis C virus after just four weeks. http://www.ibtimes.com/articles/20080107/pharmasset-up-on-hepatitis-c-data.htm Mon, 07 Jan 2008 10:32:37 EST Pharmasset Inc., a clinical-stage pharmaceutical company, said Monday its net loss narrowed during 2007 as costs and expenses rose, but revenue climbed on hefty milestone payments from Swiss drug maker Roche. http://www.ibtimes.com/articles/20071231/pharmasset-loss-narrows-in-2007.htm Mon, 31 Dec 2007 18:06:54 EST